New FDA chief wants to transform treatment

WASHINGTON — The new acting chief of the Food and Drug Administration says he will be presiding over a transformation in medicine as scientists come to understand diseases in a more detailed way that could improve doctors' ability to treat patients.

By John J. Lumpkin, Associated Press
September 25, 2005

Read the full story at washingtonpost.com.